Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2024-12-05 00:00:00 ET · period of report 2024-12-03 · accession 0001140361-24-048536 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-05 | 2024-12-03 | ROIV | Sukhatme Mayukh | Pres, CIO, Dir | J - Other | $12.21 | -3.65M | 18.84M | -16% | -$44.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-12-03 | J | D | 3,651,985 | $12.21 | 18,836,547 | D | — | — |